Characterization of PMI-5011 on the Regulation of Deubiquitinating Enzyme Activity in Multiple Myeloma Cell Extracts
Deubiquitinating enzyme (DUB)-targeted therapeutics have shown promise in recent years as alternative cancer therapeutics, especially when coupled with proteasome-based inhibitors. While a majority of DUB-based therapeutics function by inhibiting DUB enzymes, studies show that positive regulation of...
Ausführliche Beschreibung
Bibliographische Detailangaben
| Veröffentlicht in: | Biochemical engineering journal. - 1998. - 166(2021) vom: 28. Feb.
|
|---|
| 1. Verfasser: |
Vaithiyanathan, Manibarathi
(VerfasserIn) |
|---|
| Weitere Verfasser: |
Yu, Yongmei,
Rahnama, Alireza,
Pettigrew, Jacob H,
Safa, Nora,
Liu, Dong,
Gauthier, Ted J,
Floyd, Z Elizabeth,
Melvin, Adam T |
|---|
| Format: | Online-Aufsatz
|
|---|
| Sprache: | English |
|---|
| Veröffentlicht: |
2021
|
|---|
| Zugriff auf das übergeordnete Werk: | Biochemical engineering journal
|
|---|
| Schlagworte: | Journal Article |
|---|